Crowded Hedge Fund Positions
10.58k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks with highest percentage of hedge fund ownership.
Curated by Yahoo Finance
Follow this list to discover and track stocks with highest percentage of hedge fund ownership.
Background
The Yahoo Finance Crowded Hedge Fund Positions list tracks the positions with the highest hedge fund concentration. Investors follow crowded hedge fund trades as a possible source of returns and an important component of risk management. Though Crowded Hedge Fund Positions have historically outperformed the market, in times of stress, they have become increasingly volatile and underperformed the market over time.
How did we choose these stocks?Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists. We calculate the concentration of hedge fund holders over the total institutional ownership of all stocks in the investable universe. Those with the highest concentration are considered crowded hedge fund positions.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| Crowded Hedge Fund Positions | +0.23% | +47.75% | +10.12% | +19.69% |
| ^GSPC | +0.03% | +3.71% | +26.17% | +5605.42% |
31 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| GEV | GE Vernova Inc. | 178.09 | +0.66 | +0.37% | 4:00 p.m. EDT | 2.60M | 5.18M | 48.81B |
| SN | SharkNinja, Inc. | 74.89 | -1.99 | -2.59% | 4:00 p.m. EDT | 1.35M | 1.09M | 10.47B |
| SOLV | Solventum Corporation | 59.86 | -0.59 | -0.98% | 4:00 p.m. EDT | 1.70M | 2.64M | 10.34B |
| RDDT | Reddit, Inc. | 58.49 | +3.77 | +6.89% | 4:02 p.m. EDT | 3.49M | 6.05M | 9.56B |
| EDR | Endeavor Group Holdings, Inc. | 26.75 | -0.02 | -0.07% | 4:00 p.m. EDT | 2.61M | 4.66M | 8.09B |
| AS | Amer Sports, Inc. | 15.22 | +0.40 | +2.70% | 4:00 p.m. EDT | 1.37M | 1.65M | 7.69B |
| CERE | Cerevel Therapeutics Holdings, Inc. | 41 | -0.33 | -0.80% | 4:00 p.m. EDT | 1.24M | 1.16M | 7.47B |
| GGAL | Grupo Financiero Galicia S.A. | 33.07 | +0.60 | +1.85% | 4:00 p.m. EDT | 1.07M | 1.03M | 6.64B |
| BROS | Dutch Bros Inc. | 35.3 | +1.20 | +3.52% | 4:00 p.m. EDT | 2.51M | 2.49M | 6.25B |
| KVYO | Klaviyo, Inc. | 23.49 | -0.03 | -0.13% | 4:00 p.m. EDT | 1.00M | 1.21M | 6.21B |
| BLCO | Bausch + Lomb Corporation | 15.34 | +0.32 | +2.13% | 4:00 p.m. EDT | 299.89k | 468.12k | 5.42B |
| SSL | Sasol Limited | 6.99 | -0.23 | -3.19% | 4:00 p.m. EDT | 786.73k | 647.12k | 4.55B |
| ALIT | Alight, Inc. | 7.9 | -0.29 | -3.54% | 4:00 p.m. EDT | 5.56M | 5.59M | 4.54B |
| PAM | Pampa Energía S.A. | 47.66 | +1.94 | +4.24% | 4:00 p.m. EDT | 295.36k | 361.80k | 3.45B |
| MRUS | Merus N.V. | 54.87 | -5.12 | -8.53% | 4:00 p.m. EDT | 3.86M | 826.96k | 3.22B |
| ZGN | Ermenegildo Zegna N.V. | 12.43 | -0.19 | -1.51% | 4:00 p.m. EDT | 327.60k | 750.44k | 3.11B |
| UBSFY | Ubisoft Entertainment SA | 4.68 | -0.02 | -0.43% | 3:55 p.m. EDT | 10.36k | 37.44k | 3.04B |
| TBBB | BBB Foods Inc. | 26.8 | -1.44 | -5.10% | 4:00 p.m. EDT | 665.86k | 893.54k | 3.01B |
| RLX | RLX Technology Inc. | 1.91 | - | - | 4:00 p.m. EDT | 2.94M | 4.93M | 3.00B |
| OLK | Olink Holding AB (publ) | 24.02 | +0.05 | +0.21% | 4:00 p.m. EDT | 259.14k | 337.82k | 2.99B |
| CAAP | Corporación América Airports S.A. | 18.51 | +0.61 | +3.41% | 4:00 p.m. EDT | 182.13k | 150.62k | 2.98B |
| XENE | Xenon Pharmaceuticals Inc. | 38.61 | +0.24 | +0.63% | 4:00 p.m. EDT | 234.24k | 341.92k | 2.91B |
| BBAR | Banco BBVA Argentina S.A. | 9.96 | +0.12 | +1.22% | 4:00 p.m. EDT | 970.73k | 1.22M | 2.82B |
| MANU | Manchester United plc | 16.25 | -0.55 | -3.27% | 4:00 p.m. EDT | 340.41k | 674.84k | 2.75B |
| PAY | Paymentus Holdings, Inc. | 19.11 | +0.04 | +0.21% | 4:00 p.m. EDT | 181.88k | 416.56k | 2.37B |
| CLDX | Celldex Therapeutics, Inc. | 35.38 | -1.54 | -4.17% | 4:00 p.m. EDT | 1.05M | 806.25k | 2.33B |
| VZIO | VIZIO Holding Corp. | 10.57 | -0.05 | -0.47% | 4:00 p.m. EDT | 1.86M | 2.70M | 2.10B |
| VERA | Vera Therapeutics, Inc. | 37.13 | +0.02 | +0.05% | 4:00 p.m. EDT | 830.35k | 966.94k | 2.03B |
| CEPU | Central Puerto S.A. | 9.91 | +0.43 | +4.54% | 4:00 p.m. EDT | 338.60k | 401.98k | 1.99B |
| NPWR | NET Power Inc. | 10.48 | -0.28 | -2.60% | 4:00 p.m. EDT | 549.57k | 387.30k | 756.27M |
GlobeNewswireMerus N.V. Announces Proposed Public Offering of Common Shares
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares (the “Offer Shares”). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underw
Business WireBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
VAUGHAN, Ontario, May 28, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 12 ePosters during the American Optometric Association (AOA) Optometry’s Meeting ePoster Session, taking place virtually May 29-30, 2024. The company will also have three live presentations and host nine education events during the in-person meeting, taking place in Nashville June 19-22, 2024.
GlobeNewswireXenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner (XEN1101) clinical data in major depressive disorder (MDD) at the American Society of Clinical Psychopharmacology (ASCP) 2024 Annual Meeting in Miami, FL. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer, stated, “We are pleased to present these data from our Phase 2 proof-of-
